1. Home
  2. BFST vs IVA Comparison

BFST vs IVA Comparison

Compare BFST & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Business First Bancshares Inc.

BFST

Business First Bancshares Inc.

HOLD

Current Price

$27.88

Market Cap

739.5M

Sector

Finance

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.62

Market Cap

769.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFST
IVA
Founded
2006
2011
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
739.5M
769.0M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
BFST
IVA
Price
$27.88
$4.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$30.50
$17.14
AVG Volume (30 Days)
129.8K
182.3K
Earning Date
01-22-2026
09-29-2025
Dividend Yield
2.17%
N/A
EPS Growth
11.95
N/A
EPS
2.60
N/A
Revenue
$303,637,000.00
$19,929,536.00
Revenue This Year
$24.49
N/A
Revenue Next Year
$17.06
N/A
P/E Ratio
$10.67
N/A
Revenue Growth
21.51
N/A
52 Week Low
$20.07
$2.11
52 Week High
$28.96
$7.98

Technical Indicators

Market Signals
Indicator
BFST
IVA
Relative Strength Index (RSI) 72.67 56.73
Support Level $26.28 $4.32
Resistance Level $28.05 $4.61
Average True Range (ATR) 0.47 0.21
MACD 0.10 0.07
Stochastic Oscillator 93.30 99.29

Price Performance

Historical Comparison
BFST
IVA

About BFST Business First Bancshares Inc.

Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: